Pune, India, June 07, 2023 (GLOBE NEWSWIRE) — The Insight Partners published newest study study on “Molecular Diagnostics Marketplace Size Report, Share, Income, Development Approach, Sector Trends and Forecast to 2028 – COVID-19 Influence and Worldwide Evaluation By Illness Location, Technologies, Solution and Solutions, and Finish User”, the worldwide molecular diagnostics industry size is anticipated to develop from USD 16,258.97 million in 2021 and is anticipated to attain USD 36,176.65 million in 2028 it is estimated to record a CAGR of 12.1% from 2022-2028.

Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00003124

Molecular Diagnostics Marketplace Report Scope, Segmentations, Regional &amp Nation Scope:

Report CoverageInformationMarketplace Size Worth inUSD 16,258.97 million in 2021Market Size Worth byUSD 36,176.65 million by 2028Growth rateCAGR of 12.1% from 2022 to 2028Forecast Period2022-2028Base Year2021No. of Pages253No. of Tables168No. of Charts &amp Figures94Historical information availableYesSegments coveredDisease Location, Technologies, Solution and Solutions, and Finish UserRegional scopeNorth America Europe Asia Pacific Latin America MEACountry scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, ArgentinaReport coverageRevenue forecast, firm ranking, competitive landscape, development variables, and trendsCompanies CoveredAbbott, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., TBG Diagnostics Restricted, QIAGEN, bioMérieux SA, Siemens Healthineers AG, Illumina, Inc., Danaher, Novartis AG

Browse crucial industry insights spread across 253 pages with 168 list of tables &amp 94 list of figures from the report, “Molecular Diagnostics Marketplace Forecast to 2028 – COVID-19 Influence and Worldwide Evaluation by Illness Location (Oncology, Infectious Illness, Genetic Testing, Cardiac Ailments, Immune Method Problems, and Other individuals) Technologies [Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others] Solution and Solutions (Assays and Kits, Instruments, Solutions and Software program) Finish User (Hospitals and Clinics, Diagnostic Laboratories, Study and Academic Institutes, and Other individuals)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/molecular-diagnostics-industry

Worldwide Molecular Diagnostics Marketplace Evaluation: Competitive Landscape and Crucial Developments
Abbott, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., TBG Diagnostics Restricted, QIAGEN, bioMérieux SA, Siemens Healthineers AG, Illumina, Inc., Danaher, Novartis AG amongst other people is a handful of of the crucial businesses operating in the molecular diagnostics industry. The industry leaders concentrate on new solution launches, expansion and diversification, and acquisition approaches, which let them to access prevailing business enterprise possibilities.

In November 2021, Thermo Fisher Scientific Inc., the globe leader in serving science, has revolutionary proteomics options and a series of co-marketing and advertising agreements with market professionals, advancing the throughput, comprehensiveness and good quality of proteomics workflows for applications such as single-cell research and translational study.

In November 2021, as assay developers and clinical testing laboratories take into account subsequent methods for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD) technique from Thermo Fisher Scientific will allow them to expand their assay menus and IVD testing capabilities moving forward.

In October 2021, Agilent Technologies Inc. has announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA authorized as an help in identifying sufferers with early breast cancer (EBC) at higher danger of illness recurrence, for whom adjuvant therapy with Verzenio (abemaciclib) in mixture with endocrine therapy.

Speak to Study Professional: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00003124

Worldwide and Regional Players to Discover Untapped Markets Supplies Profitable Possibilities for Molecular Diagnostics Marketplace:
The building regions such as Asia Pacific in healthcare-associated markets. The region’s crucial economies, such as, Australia, China, Japan, India, South Korea, and other people, have a nicely-established healthcare technique. With the availability of raw components and manpower at affordable prices, numerous worldwide and regional players, operating the molecular diagnostics-associated markets, are setting up their facilities in this area. They are also focusing actively on introducing their merchandise in APAC. For instance, in March 2020, Biolidics launched its ten-minute speedy test kits for COVID-19 in Singapore. It received provisional authorization from Singapore Wellness Science Authority (HSA). The active participation of region’s regulatory agencies and industry players is anticipated to offer you prospective possibilities for the development of the molecular diagnostics industry for the duration of the forecast period.

Molecular Diagnostics Marketplace: Segmental Overview
Primarily based on illness location, the molecular diagnostics industry is segmented into oncology, infectious illness, genetic testing, cardiac ailments, immune technique issues and other people. Primarily based on technologies, the industry is segmented into is segmented into polymerase chain reaction (PCR), isothermal nucleic acid amplification technologies (INAAT), DNA sequencing and subsequent-generation sequencing (NGS), in situ hybridization (ISH), DNA microarray, and other technologies. Primarily based on primarily based on solution and solutions, the industry has been segmented into assays and kits, instruments, and solutions and application. Primarily based on finish user, the industry is segmented into hospitals and clinics, diagnostic laboratories, study and academic institutes, and other people.

Inquiry Ahead of Buy: https://www.theinsightpartners.com/inquiry/TIPRE00003124

The enhance in demand for point-of-care and developments by industry players, growing prevalence of connected ailments. Having said that, limitations connected the molecular testing is anticipated to restrict the industry development for the duration of the forecast period.

In North America, the US is the biggest industry for molecular diagnostics industry. The development of this industry is mostly driven by the growing prevalence of chronic kidney issues (CKD) and a increasing quantity of solution launches by crucial players. The increasing geriatric population is also 1 of the significant drivers for this industry, as aging is the prominent danger element accountable for increasing incidences of renal ailments. For instance, according to a study published by the Population Reference Bureau in 2019, the population age 65 years in the US is anticipated to double by 2060. As per published estimates, the population of the 65 years of age group is estimated to attain 95 million by 2060. Additionally, the continuous help from the US government will offer you profitable possibilities in the nation. The regulatory agencies are supplying favorable policies for the improvement of POC merchandise connected with a variety of indications. For instance, in March 2021, The US Meals Drug Administration (FDA) authorized for very first Point-of-Care Chlamydia and Gonorrhea Test of Binx Wellness IO CT/NG Assay at point-of-care settings, such as in neighborhood-primarily based clinics, urgent care settings, outpatient well being care facilities, and other patient care settings.

Additionally, numerous other variables that are accountable for advertising the development of the industry in the US contains international players take efforts to penetrate into the US industry, advancements in the diagnostics by way of in depth study and innovation undertaken by top players as nicely as growing awareness amongst the finish-customers.

Get Premium Copy of Molecular Diagnostics Marketplace Development Report (2022-2028) at: https://www.theinsightpartners.com/obtain/TIPRE00003124

Go by way of additional study published by The Insight Partners: (Buy with ten% Immediate Discount):

Point-of-Care Molecular Diagnostics Marketplace Forecast to 2028 – COVID-19 Influence and Worldwide Evaluation

Viral Molecular Diagnostics Marketplace Forecast to 2028 – COVID-19 Influence and Worldwide Evaluation

PCR and NGS-Primarily based Molecular Diagnostics Marketplace Forecast to 2028 – COVID-19 Influence and Worldwide Evaluation

About Us:
The Insight Partners is a 1 quit market study provider of actionable intelligence. We enable our consumers in finding options to their study needs by way of our syndicated and consulting study solutions. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Building, Healthcare Device, Technologies, Media and Telecommunications, Chemical compounds and Components.

Get in touch with Us:
If you have any queries about this report or if you would like additional info, please make contact with us:

Get in touch with Particular person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Telephone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/molecular-diagnostics-industry
Sector Study: https://www.biospace.com/employer/2735308/the-insight-partners/